# Japanese IP-TN Trial

> **NCT02831569** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 80 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Loxoprofen sodium
- **DRUG:** Methocarbamol

## Key facts

- **NCT ID:** NCT02831569
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-27
- **Primary completion:** 2016-10-19
- **Final completion:** 2016-10-19
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02831569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02831569, "Japanese IP-TN Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02831569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*